Alibaba Health Information Technology (0241) Price & Analysis

Compare

22 Followers

0241 Stock Chart & Stats

HK$5.14

HK$0.03(0.93%)

At close: Jan 09 4:00 PM EST

HK$5.14

HK$0.03(0.93%)

Day’s Range― - ―

52-Week RangeHK$3.09 - HK$7.50

Previous CloseN/A

Volume38.53M

Average Volume (3M)83.52M

Market Cap

HK$83.11B

Enterprise ValueHK$0.00

Total Cash (Recent Filing)HK$9.39B

Total Debt (Recent Filing)HK$82.96M

Price to Earnings (P/E)39.6

Beta2.16

Next Earnings

May 26, 2026

EPS Estimate

0.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.09

Shares Outstanding16,174,728,000

10 Day Avg. Volume99,710,369

30 Day Avg. Volume83,522,295

Financial Highlights & Ratios

PEG Ratio1.17

Price to Book (P/B)4.33

Price to Sales (P/S)2.31

P/FCF Ratio51.28

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$5.75

Price Target Upside11.96% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering5

EPS Forecast (FY)0.16

Revenue Forecast (FY)HK$38.94B

Bulls Say, Bears Say

Bulls Say

Financial PerformanceAdjusted net profit estimates have been increased significantly, reflecting a positive outlook for the company's financial performance.

Product DemandWeight-loss drugs grew over 100% in the first half, showcasing strong product demand.

Revenue GrowthRevenue growth is expected to be strong due to sales momentum in the online drug segment and updated company guidance.

Bears Say

Growth SlowdownFY2026 guidance implies a potential slowdown in second-half year-over-year growth.

Price Target RisksThere is an indicated downside to the price target, suggesting potential risks to achieving the target.

Alibaba Health Information Technology News

Alibaba Health Grants 3.5 Million RSUs to Employees

Alibaba Health Information Technology ( ($HK:0241) ) has provided an announcement. Alibaba Health Information Technology Limited has announced...

11d ago

Leadership Transition at Alibaba Health Information Technology

The latest update is out from Alibaba Health Information Technology ( ($HK:0241) ). Alibaba Health Information Technology Limited...

12d ago

Alibaba Health Announces New Board of Directors

Alibaba Health Information Technology ( ($HK:0241) ) has provided an announcement. Alibaba Health Information Technology Limited has announced...

12d ago

Cautious Stance on Alibaba Health: Sell Rating Amid Limited Upside Potential

Morgan Stanley analyst Alexis Yan maintained a Sell rating on Alibaba Health Information Technology today and set a...

15d ago

Alibaba Health Announces Special General Meeting for Revised Marketing Caps

The latest announcement is out from Alibaba Health Information Technology ( ($HK:0241) ). Alibaba Health Information Technology Limited...

20d ago

Sell Rating for Alibaba Health Due to Growth Deceleration and Competitive Pressures

In a report released yesterday, Alexis Yan from Morgan Stanley maintained a Sell rating on Alibaba Health Information...

29d ago

Alibaba Health Reports Strong Financial Growth

Alibaba Health Information Technology ( ($ALBHF) ) has released its Q2 earnings. Here is a breakdown of the...

1M ago

Alibaba Health Reports Strong Interim Results and Strategic AI Investments

Alibaba Health Information Technology ( ($HK:0241) ) has provided an update. Alibaba Health Information Technology Limited reported a...

1M ago

Alibaba Health Revises Annual Caps for 2025–2027 Marketing Agreement

Alibaba Health Information Technology ( ($HK:0241) ) has shared an update. Alibaba Health Information Technology Limited has announced...

1M ago

Alibaba Health Schedules Board Meeting to Review Interim Results

Alibaba Health Information Technology ( ($HK:0241) ) has provided an update. Alibaba Health Information Technology Limited has announced...

1M ago

0241 FAQ

What was Alibaba Health Information Technology’s price range in the past 12 months?

Alibaba Health Information Technology lowest stock price was HK$3.09 and its highest was HK$7.50 in the past 12 months.

What is Alibaba Health Information Technology’s market cap?

Alibaba Health Information Technology’s market cap is HK$83.11B.

When is Alibaba Health Information Technology’s upcoming earnings report date?

Alibaba Health Information Technology’s upcoming earnings report date is May 26, 2026 which is in 150 days.

How were Alibaba Health Information Technology’s earnings last quarter?

Alibaba Health Information Technology released its earnings results on Nov 26, 2025. The company reported HK$0.093 earnings per share for the quarter, beating the consensus estimate of HK$0.088 by HK$0.004.

Is Alibaba Health Information Technology overvalued?

According to Wall Street analysts Alibaba Health Information Technology’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Alibaba Health Information Technology pay dividends?

Alibaba Health Information Technology does not currently pay dividends.

What is Alibaba Health Information Technology’s EPS estimate?

Alibaba Health Information Technology’s EPS estimate is 0.08.

How many shares outstanding does Alibaba Health Information Technology have?

Alibaba Health Information Technology has 16,174,728,000 shares outstanding.

What happened to Alibaba Health Information Technology’s price movement after its last earnings report?

Alibaba Health Information Technology reported an EPS of HK$0.093 in its last earnings report, beating expectations of HK$0.088. Following the earnings report the stock price went up 2.007%.

Which hedge fund is a major shareholder of Alibaba Health Information Technology?

Currently, no hedge funds are holding shares in HK:0241

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Alibaba Health Information Technology Stock Smart Score

Neutral

Fundamentals

Return on Equity

11.53%

Trailing 12-Months

Asset Growth

13.13%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Alibaba Health Information Technology

Alibaba Health Information Technology (0241) is a leading healthcare technology company based in China, primarily focused on leveraging digital solutions to enhance health services and facilitate healthcare management. The company operates in various sectors, including health information systems, online pharmacies, and telemedicine services. Its core products and services include a comprehensive health management platform, electronic health records, and a marketplace for pharmaceutical products, aimed at improving access to healthcare and streamlining health management for both consumers and healthcare providers.

Alibaba Health Information Technology (0241) Earnings & Revenues

Historic Earnings Reports

0241 Stock 12 Month Forecast

Average Price Target

HK$5.75

▲(11.96% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"HK$1","8":"HK$8","2.75":"HK$2.75","4.5":"HK$4.5","6.25":"HK$6.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7.0770857976,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$7.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.7549928464,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$5.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.5884402424,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$4.59</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.75,4.5,6.25,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.51,5.630545061353846,5.7510901227076925,5.871635184061538,5.992180245415384,6.112725306769231,6.233270368123077,6.3538154294769225,6.474360490830769,6.594905552184615,6.7154506135384615,6.835995674892308,6.956540736246153,{"y":7.0770857976,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.51,5.528845603569231,5.547691207138461,5.566536810707692,5.585382414276923,5.604228017846154,5.623073621415385,5.6419192249846155,5.660764828553846,5.679610432123077,5.698456035692308,5.717301639261539,5.73614724283077,{"y":5.7549928464,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.51,5.439110787876923,5.368221575753846,5.297332363630769,5.226443151507692,5.155553939384615,5.084664727261538,5.0137755151384615,4.942886303015385,4.871997090892307,4.801107878769231,4.730218666646154,4.659329454523077,{"y":4.5884402424,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.96,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.35,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.889,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.67,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.73,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.51,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.74,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.82,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.84,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.66,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.8,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.51,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >